The Greatest Value From AI Scribes May Come From Influencing Decisions, Not Documenting Them
Healthcare has undergone a significant transformation in recent years, moving away from its reputation as a digital laggard to becoming one of the fastest-adopting sectors for domain-specific AI. With nearly a quarter of provider organizations now utilizing specialized AI tools, the industry has seen a sevenfold increase since 2024 and a tenfold increase since 2023.
A major driver of this adoption has been the rise of ambient AI medical scribes, with over $600 million already spent on scribe deployments accounting for nearly 45% of all inpatient and outpatient AI spending. Venture investment in AI scribe companies has also surged, with companies like Abridge, Ambience, and DAX Copilot raising significant funding in the past 18 months.
Ambient scribes offer a clear return on investment by reducing documentation burden, improving coding accuracy, and alleviating physician burnout. However, it is crucial to understand that while scribes can capture conversations and format clinical documentation, they do not directly impact the decision-making process of clinicians.
The real leverage in healthcare lies in influencing the decisions that clinicians make, as these decisions not only impact patient care but also have significant economic implications. The ability to shape decisions, not just document them, can have far-reaching effects on cost, revenue, risk exposure, and overall healthcare outcomes.
The history of influencing physicians in healthcare dates back decades, from pharmaceutical detailing to evidence-based reference tools like UpToDate. The evolution of influence has now shifted towards AI-driven clinical decision support (CDS), combining the immediacy of EHR nudges, the authority of evidence-based references, and the personalization of real-world patient data.
In the competitive landscape of AI CDS, moats play a crucial role in determining the success of a platform. Moats such as real-world data scale, curated expert content, network effects, workflow control, pharma monetization power, and ambient documentation integration define the competitive frontier of CDS.
The future of healthcare AI lies in systems that can shape decisions, not just alleviate administrative burden. Organizations with defensible moats, including proprietary data, editorial authority, workflow ownership, network distribution, and revenue advantage, will be at the forefront of shaping clinical practice and influencing healthcare outcomes.
In conclusion, the healthcare industry’s adoption of AI-driven technologies is reshaping the way decisions are made in clinical settings. By leveraging AI-driven CDS platforms with strong moats, healthcare organizations can drive better outcomes, improve efficiency, and ultimately shape the future of healthcare delivery.
